Catalyst OrthoScience was granted FDA 510(k) clearance to market its reverse shoulder system. Limited U.S. launch will begin in 2Q21, followed by commercial launch later this year.
Catalyst’s reverse shoulder system is a single-tray arthroplasty system engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The system offers surgeon-targeted implant positioning, a streamlined and versatile system and bone sparing implants.
“With the addition of our reverse shoulder system, Catalyst is now addressing the two fastest growing segments of the shoulder arthroplasty market – stemless anatomic and reverse TSA,” said Brian K. Hutchison, Chairman and CEO of Catalyst.
Catalyst OrthoScience was granted FDA 510(k) clearance to market its reverse shoulder system. Limited U.S. launch will begin in 2Q21, followed by commercial launch later this year.
Catalyst’s reverse shoulder system is a single-tray arthroplasty system engineered to combine the most beneficial and evidence-based attributes of reverse...
Catalyst OrthoScience was granted FDA 510(k) clearance to market its reverse shoulder system. Limited U.S. launch will begin in 2Q21, followed by commercial launch later this year.
Catalyst’s reverse shoulder system is a single-tray arthroplasty system engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The system offers surgeon-targeted implant positioning, a streamlined and versatile system and bone sparing implants.
“With the addition of our reverse shoulder system, Catalyst is now addressing the two fastest growing segments of the shoulder arthroplasty market – stemless anatomic and reverse TSA,” said Brian K. Hutchison, Chairman and CEO of Catalyst.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.